paxilline has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, KS; Li, CL; Lin, MW; Ting, WH; Wu, AZ; Wu, SN | 1 |
| Bahranian, A; Dilmaghani, NA; Eslami, S; Ghafouri-Fard, S; Safarzadeh, A; Sharifi, G; Taheri, M | 1 |
2 other study(ies) available for paxilline and Pituitary Neoplasms
| Article | Year |
|---|---|
Changes in membrane cholesterol of pituitary tumor (GH3) cells regulate the activity of large-conductance Ca2+-activated K+ channels.
Topics: Action Potentials; Animals; Apamin; beta-Cyclodextrins; Caffeic Acids; Calcium; Cholesterol; Cilostazol; Dexamethasone; Diazoxide; Glyburide; Indoles; Ion Channel Gating; Large-Conductance Calcium-Activated Potassium Channels; Membrane Lipids; Phenylethyl Alcohol; Pituitary Neoplasms; Rats; Tetrazoles; Tumor Cells, Cultured | 2006 |
Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma.
Topics: Gene Expression Regulation, Neoplastic; Humans; Iran; Nuclear Proteins; Paxillin; Pituitary Neoplasms; RNA, Long Noncoding; Up-Regulation | 2023 |